Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007

August 16, 2010 updated by: Tehran University of Medical Sciences

Screening of Menstrual Disorder in Elite Feamle Athlete in Iran

Women's evermore presence in professional and athletic sports has revealed sound evidence on the existence of female athlete triad among the world's elite female athletes. This triad consists of eating disorders, amenorrhea and osteoporosis. It has been stated that all female athletes are potentially at risk, but it is not clear to what extent those exercising at different levels are at risk of this syndrome/triad. Since the manifestation of this triad is often denied, or under-reported, appropriate screening methods are required to identify the symptoms. There is still no clear-cut information available on the incidence of this triad in Iran. And there are religious and cultural differences between Iran's elite female athletes and those in other countries. Therefore, in order to meet Iranian female athletes' needs, the investigators decided to determine the frequency of the female athlete triad in Iran.

Study Overview

Status

Terminated

Conditions

Study Type

Observational

Enrollment (Anticipated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 45 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Study population: Professional Iranian female athletes who are members in national teams or federations sports and champion team in Tehran

Description

Inclusion Criteria:

  • All Elite Female athletes who play in international teams in sport federation or champion Team in Tehran between 13-45 years old.

Exclusion Criteria:

  • The 13-15 year old female athletes who are not manarch with secondary sex charactristics.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Female athlete Triad syndrom was based on menstrual disorder,Eating Disorder and bone loss

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Prevalence of Female Athlete Triad among Elite female athlete in Iran in 2006
Time Frame: 24 month
24 month

Secondary Outcome Measures

Outcome Measure
Time Frame
prevalence of menstrual disorder in female athlete in Iran in 2006
Time Frame: 24 month
24 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tehran University of Medical Sciences

Investigators

  • Study Director: Haleh Dadgostar, MD, Rheumatology Research Center, Tehran University for Medical Sciences
  • Principal Investigator: Shafie Movaseghi, MD, Rheumatology Research Center, Tehran University for Medical Sciences
  • Principal Investigator: ashraf Aleyasin, MD, Tehran University for Medical Sciences
  • Principal Investigator: mohamad hosein Forozanfar, MD, Rheumatology Research Center, Tehran University for Medical Sciences
  • Principal Investigator: Talia Alenabi, MD, Sport Medicine Federation of Islamic Republic Of Iran
  • Principal Investigator: Narges Chime, MD, Shahid Beheshti University of Medical Sciences
  • Principal Investigator: pooneh Kimia ghalam, MD, Health ministry of Iran

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2006

Primary Completion (Actual)

February 1, 2009

Study Completion (Anticipated)

March 1, 2009

Study Registration Dates

First Submitted

August 13, 2010

First Submitted That Met QC Criteria

August 16, 2010

First Posted (Estimate)

August 17, 2010

Study Record Updates

Last Update Posted (Estimate)

August 17, 2010

Last Update Submitted That Met QC Criteria

August 16, 2010

Last Verified

August 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 85-01-41-3488

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menstruation Disturbances

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe